Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$9.38M Buy
170,650
+83,196
+95% +$4.43M 1.16% 13
2016
Q1
$4.42M Buy
87,454
+25,666
+42% +$1.26M 0.77% 25
2015
Q4
$3.11M Sell
61,788
-4,868
-7% -$245K 0.73% 33
2015
Q3
$3.14M Sell
66,656
-6,410
-9% -$341K 0.72% 30
2015
Q2
$3.97M Buy
73,066
+11,106
+18% +$623K 0.81% 20
2015
Q1
$3.4M Buy
61,960
+3,120
+5% +$177K 0.8% 16
2014
Q4
$3.19M Buy
+58,840
New +$3.28M 1.41% 18

Other funds holding MRK

Lebenthal Holdings's MRK Position: Q2 2016 in Review

Lebenthal Holdings increased its Merck (MRK) stake by 95% in Q2 2016, buying an estimated $4.43M and bringing the position to 170,650 shares worth $9.38M. The position accounts for 1.16% of the portfolio, ranked #13.

Lebenthal Holdings first reported a position in MRK in Q4 2014 and has held it in 7 quarters since. 1,761 funds tracked by Wall St. Rank hold MRK as of Q2 2016.

  • Lebenthal Holdings held 170,650 shares of Merck worth $9.38M as of Q2 2016.
  • Lebenthal Holdings bought 83,196 Merck shares in Q2 2016, an estimated $4.43M.
  • Merck made up 1.16% of Lebenthal Holdings's portfolio in Q2 2016, its #13 holding.
  • Lebenthal Holdings first reported a position in Merck in Q4 2014 and has held it in 7 quarters since.
  • 1,761 funds tracked by Wall St. Rank held Merck as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.